July 3, 6:12 PMVaccines ExaminerNorma Erickson
Sin Hang Lee M.D., F.R.C.P. (C), FCAP has over 50 years’ experience in general/surgical pathology and clinical microbiology. He is qualified to practice in the U.S., Canada, and the United Kingdom.
Dr. Lee is currently a practicing pathologist at Milford Hospital, in Milford CT, and the Director of Milford Medical Laboratory, which is an industry leader in the development of molecular diagnostic procedures. One of their goals is to facilitate the transfer of advanced PCR/direct DNA sequencing technology into community hospital laboratories.
Milford Medical Laboratory’s (MML) molecular diagnostics department has introduced the nation’s first routine DNA sequencing-based no-false positive HPV genotyping, Neisseria gonorrhoeae opa gene DNA amplification assay, and Chlamydia trachomatis cryptic plasmid DNA amplification assay for women’s health care management. MML also assists CLIA-certified laboratories establish their own in-house molecular sequencing programs.
Dr. Lee is also the president of HiFi DNA Tech, LLC, a biotechnology company providing cutting-edge molecular tests developed by pathologists and cytotechnologists for pathologists and cytotechnologists to serve gynecologists and their patients at sustainable cost.
During recent phone conversations and emails, Dr. Lee has expressed several concerns for the health and safety of women, particularly in the United States. He would like to get these messages out to the general public so they can make informed decisions regarding their medical care and treatment options: